Literature DB >> 6293410

Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus.

T R Doel, W K Chong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6293410     DOI： 10.1007/bf01314726

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


× No keyword cloud information.
  12 in total

1.  A 65 S PARTICLE CONTAINING VIRAL PROTEIN IN CELLS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS.

Authors:  D N PLANTEROSE; J K RYAN
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

2.  Morphogenesis of foot-and-mouth disease virus. I. Role of procapsids as virion Precursors.

Authors:  A G Yafal; E L Palma
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

Review 3.  Antibody response to viral antigens.

Authors:  K M Cowan
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Chemical and physical properties of foot-and-mouth disease virus: a comparison with Maus Elberfeld virus.

Authors:  G F Vande Woude; J B Swaney; H L Bachrach
Journal:  Biochem Biophys Res Commun       Date:  1972-09-05       Impact factor: 3.575

5.  Further evidence for multiple proteins in the foot-and-mouth disease virus particle.

Authors:  J N Burroughs; D J Rowlands; D V Sangar; P Talbot; F Brown
Journal:  J Gen Virol       Date:  1971-10       Impact factor: 3.891

6.  A study of the physical properties of the immunizing antigen of foot-and-mouth disease virus and the effect of various inactivating agents on its structure.

Authors:  T F Wild; F Brown
Journal:  Arch Gesamte Virusforsch       Date:  1968

7.  Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccines.

Authors:  T R Doel; T Collen
Journal:  J Biol Stand       Date:  1982-04

8.  A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus.

Authors:  D J Rowlands; D V Sangar; F Brown
Journal:  J Gen Virol       Date:  1975-03       Impact factor: 3.891

9.  Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease.

Authors:  S M Golding; R S Hedger; P Talbot
Journal:  Res Vet Sci       Date:  1976-03       Impact factor: 2.534

10.  Biochemical mapping of the foot-and-mouth disease virus genome.

Authors:  D V Sangar; D N Black; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1977-05       Impact factor: 3.891
View more
  23 in total

1.  Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins.

Authors:  J Chinsangaram; C Beard; P W Mason; M K Zellner; G Ward; M J Grubman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus.

Authors:  Haiwei Wang; Shanshan Song; Jianxiong Zeng; Guohui Zhou; Decheng Yang; Te Liang; Li Yu
Journal:  Virol Sin       Date:  2014-03-26       Impact factor: 4.327

3.  Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus.

Authors:  S Curry; E Fry; W Blakemore; R Abu-Ghazaleh; T Jackson; A King; S Lea; J Newman; D Stuart
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus.

Authors:  Ya Gao; Pinghua Li; Xueqing Ma; Xingwen Bai; Pu Sun; Ping Du; Hong Yuan; Yimei Cao; Kun Li; Yuanfang Fu; Jing Zhang; Huifang Bao; Yingli Chen; Zhiyong Li; Zengjun Lu; Zaixin Liu; Dong Li
Journal:  Arch Virol       Date:  2021-05-18       Impact factor: 2.574

5.  Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids.

Authors:  S Curry; C C Abrams; E Fry; J C Crowther; G J Belsham; D I Stuart; A M King
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability.

Authors:  Katherine A Scott; Abhay Kotecha; Julian Seago; Jingshan Ren; Elizabeth E Fry; David I Stuart; Bryan Charleston; Francois F Maree
Journal:  J Virol       Date:  2017-04-28       Impact factor: 6.549

7.  Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design.

Authors:  Abhay Kotecha; Julian Seago; Katherine Scott; Alison Burman; Silvia Loureiro; Jingshan Ren; Claudine Porta; Helen M Ginn; Terry Jackson; Eva Perez-Martin; C Alistair Siebert; Guntram Paul; Juha T Huiskonen; Ian M Jones; Robert M Esnouf; Elizabeth E Fry; Francois F Maree; Bryan Charleston; David I Stuart
Journal:  Nat Struct Mol Biol       Date:  2015-09-21       Impact factor: 15.369

8.  Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor.

Authors:  Soonyong Park; Ji Yul Kim; Kyoung-Hwa Ryu; Ah-Young Kim; Jaemun Kim; Young-Joon Ko; Eun Gyo Lee
Journal:  Vaccines (Basel)       Date:  2021-05-13

9.  Novel Capsid-Specific Single-Domain Antibodies with Broad Foot-and-Mouth Disease Strain Recognition Reveal Differences in Antigenicity of Virions, Empty Capsids, and Virus-Like Particles.

Authors:  Haozhou Li; Aldo Dekker; Shiqi Sun; Alison Burman; Jeroen Kortekaas; Michiel M Harmsen
Journal:  Vaccines (Basel)       Date:  2021-06-08

10.  An Engineered Maturation Cleavage Provides a Recombinant Mimic of Foot-and-Mouth Disease Virus Capsid Assembly-Disassembly.

Authors:  Joseph Newman; David J Rowlands; Tobias J Tuthill
Journal:  Life (Basel)       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.